指南与共识骨软组织肉瘤与黑色素瘤

ESMO共识会议建议:转移性黑色素瘤的管理

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.
指南 / 共识 · Ann Oncol · 2020-08-04

欧洲肿瘤内科学会(ESMO)于2019年9月5-7日在阿姆斯特丹召开黑色素瘤共识会议,由32位多学科专家组成专家组,针对当前ESMO临床实践指南未详细覆盖且证据有限或矛盾的五个主题制定建议。本文呈现转移性黑色素瘤管理相关结果,包括专家讨论、共识建议及支持证据总结,所有参与者批准最终稿件。

要点

  • 共识会议聚焦转移性黑色素瘤一线靶向与免疫治疗选择等未详述问题。
  • 建议基于工作组文献回顾与全体投票产生,所有专家批准最终稿件。
  • 本文涵盖转移性黑色素瘤管理共识建议及支持证据总结。

核心结论

  • 本文呈现ESMO共识会议关于转移性黑色素瘤管理的共识建议及支持证据总结。

研究设计与样本

  • ESMO于2019年9月5-7日在阿姆斯特丹召开共识会议,组成32位多学科专家小组。
  • 专家分为五个工作组,分别针对五个主题预先回顾文献并制定建议,再经全体讨论修改后投票。

主要发现

  • 会议识别五个讨论主题:局部区域疾病管理、辅助治疗中靶向与免疫治疗比较、转移性黑色素瘤一线靶向与免疫治疗比较、转移期免疫或靶向治疗停药时机、脑转移系统与局部治疗比较。
  • 本文呈现转移性黑色素瘤管理相关结果,包括专家讨论、共识建议及支持证据总结。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. The aim of the conference was to develop recommendations on topics that are not covered in detail in the current ESMO Clinical Practice Guideline and where available evidence is either limited or conflicting. The main topics identified for discussion were (i) the management of locoregional disease; (ii) targeted versus immunotherapies in the adjuvant setting; (iii) targeted versus immunotherapies for the first-line treatment of metastatic melanoma; (iv) when to stop immunotherapy or targeted therapy in the metastatic setting; and (v) systemic versus local treatment for brain metastases. The expert panel was divided into five working groups to each address questions relating to one of the five topics outlined above. Relevant scientific literature was reviewed in advance. Recommendations were developed by the working groups and then presented to the entire panel for further discussion and amendment before voting. This manuscript presents the results relating to the management of metastatic melanoma, including findings from the expert panel discussions, consensus recommendations and a summary of evidence supporting each recommendation. All participants approved the final manuscript.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Keilholz U, Ascierto PA, Dummer R, et al. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol. 2020. PMID: 32763453. doi:10.1016/j.annonc.2020.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。